drugset / Trial / NCT01741103
Sitagliptin in Type I Diabetic Patients
Withdrawn
University at Buffalo
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of the study is to evaluate the effect of sitagliptin on overall blood glucose concentrations in Type I Diabetic subjects. The study also aims to evaluate post meal glucagon concentrations in Type I Diabetic subjects (a possible mechanism of reduced blood glucose concentrations) and indices of oxidation stress in the plasma of these subjects.
Timeline
- Start
- 2011-06
- Primary completion
- 2013-09
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sitagliptin | Small molecule | 100 mg | Oral |